394 related articles for article (PubMed ID: 32252674)
1. Intravitreal Aflibercept injection with Panretinal photocoagulation versus early Vitrectomy for diabetic vitreous hemorrhage: randomized clinical trial.
Abd Elhamid AH; Mohamed AAEA; Khattab AM
BMC Ophthalmol; 2020 Apr; 20(1):130. PubMed ID: 32252674
[TBL] [Abstract][Full Text] [Related]
2. Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Antoszyk AN; Glassman AR; Beaulieu WT; Jampol LM; Jhaveri CD; Punjabi OS; Salehi-Had H; Wells JA; Maguire MG; Stockdale CR; Martin DF; Sun JK;
JAMA; 2020 Dec; 324(23):2383-2395. PubMed ID: 33320223
[TBL] [Abstract][Full Text] [Related]
3. Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Glassman AR; Beaulieu WT; Maguire MG; Antoszyk AN; Chow CC; Elman MJ; Jampol LM; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2021 Jul; 139(7):725-733. PubMed ID: 33956075
[TBL] [Abstract][Full Text] [Related]
4. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab.
Hu X; Pan Q; Zheng J; Song Z; Zhang Z
BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravitreal bevacizumab as a pretreatment of vitrectomy for diabetic vitreous hemorrhage on recurrent hemorrhage.
Berk Ergun S; Toklu Y; Cakmak HB; Raza S; Simsek S
Semin Ophthalmol; 2015 May; 30(3):177-80. PubMed ID: 24409948
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
Yang CS; Hung KC; Huang YM; Hsu WM
J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
Sivaprasad S; Prevost AT; Vasconcelos JC; Riddell A; Murphy C; Kelly J; Bainbridge J; Tudor-Edwards R; Hopkins D; Hykin P;
Lancet; 2017 Jun; 389(10085):2193-2203. PubMed ID: 28494920
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
Diabetic Retinopathy Clinical Research Network*
JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
Park DH; Shin JP; Kim SY
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal bevacizumab for proliferative diabetic retinopathy with new dense vitreous hemorrhage after full panretinal photocoagulation.
Sinawat S; Rattanapakorn T; Sanguansak T; Yospaiboon Y; Sinawat S
Eye (Lond); 2013 Dec; 27(12):1391-6. PubMed ID: 24037235
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
[TBL] [Abstract][Full Text] [Related]
12. The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy.
Ahn J; Woo SJ; Chung H; Park KH
Ophthalmology; 2011 Nov; 118(11):2218-26. PubMed ID: 21724263
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
[No Abstract] [Full Text] [Related]
14. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
Jiang T; Gu J; Zhang P; Chen W; Chang Q
BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
[TBL] [Abstract][Full Text] [Related]
15. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.
Chatziralli I; Dimitriou E; Theodossiadis G; Bourouki E; Bagli E; Kitsos G; Theodossiadis P
Int Ophthalmol; 2020 Apr; 40(4):841-847. PubMed ID: 31788713
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab injection for recurrent vitreous haemorrhage after diabetic vitrectomy.
Yeh PT; Yang CH; Yang CM
Acta Ophthalmol; 2011 Nov; 89(7):634-40. PubMed ID: 20064118
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Intravitreal Ranibizumab on the Surgical Outcome for Diabetic Retinopathy With Tractional Retinal Detachment.
Dong F; Yu C; Ding H; Shen L; Lou D
Medicine (Baltimore); 2016 Feb; 95(8):e2731. PubMed ID: 26937902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
